




dystrophy type 2 in
members of a chinese
family
C Chao-Shern1,2,5, R Me3,5, LA DeDionisio2,
BL Ke3, MA Nesbit1, J Marshall4 and CBT Moore1
Abstract
Purpose The post-LASIK exacerbation of
corneal dystrophy, otherwise asymptomatic,
is almost exclusively associated with the
TGFBI gene mutations at codon 124 in exon 4
and codon 555 in exon 12. It is our intention
to demonstrate that the pre-operative
genetic screening for TGFBI mutations should
be mandatory for refractive surgery
candidates.
Patients and Methods In this study, we
reviewed the proband’s post-LASIK slit-lamp
and in vivo confocal microscopy images and
genetic testing results, and performed genetic
testing on eleven additional members of the
family to investigate the penetrance of
corneal dystrophy in asymptomatic members
who carry the mutation.
Results The proband demonstrated a post-
LASIK exacerbation of Granular Corneal
Dystrophy type 2 (GCD2), identiﬁed as a
TGFBI R124H mutation. Three of the 11
family members tested positive for the same
R124H mutation as the proband.
Conclusion The lesson learned from this
case is that the genetic screening of TGFBI
mutations must be incorporated into the pre-
operative screening procedures to prevent
exacerbation and recurrence, which eventually
could lead to the need for a corneal
transplant.
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Introduction
As the ﬁrst report of autosomal-dominant
Granular Corneal Dystrophy type 2 (GCD2) in
individuals from Avellino, Italy1 in 1988, many
cases of post-laser surgery exacerbation have
been reported worldwide.1–7 Inherited corneal
dystrophy exacerbation is characterized by
bilateral opacity in anterior corneal stroma leading
to a severe decrease of the best corrected visual
acuity (BCVA) and ultimately to surgical
treatment.8–10
The Avellino Universal Test examines the ﬁve
most common TGFBI corneal dystrophies, each
triggered by different mutations in exons 4
and 12 of the TGFBI gene, located on chromosome
5q31.1. Puriﬁed DNA is extracted from oral
epithelial cells collected by buccal swabs and the
genotype of the LASIK candidate obtained by
amplifying the targeted DNA point mutations
(Table 1).
Herein, we report the results of ophthalmic
and genetic examination of an individual with




The proband is a 29-year-old Chinese male
who underwent bilateral LASIK surgery
in 2006. The post-operative uncorrected visual
acuity (UCVA) in both eyes was 20/20. He had
an uneventful post-operative course and
did not have regular follow-up examinations
after the surgery. In July 2016, 10 years after
LASIK surgery, he was referred to Shanghai
First People's Hospital for evaluation of
dryness, foreign body sensation, and mildly
decreased vision acuity in both eyes. The
ﬁndings were opacities in both of his corneas.
Slip-lamp examination was conducted
(Figure 1a and b). His UCVA was 16/20 in
the right eye and 12/20 in the left eye. The
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× 30 oculus dexter and − 0.5 oculus sinister, yielding a
BCVA of 20/20 in the right eye and 16/20 in the left eye.
Subsequent examination
by in vivo confocal microscopy (IVCM) revealed a large
quantity of dense white deposits of various shapes and
sizes which presented as hyper-reﬂective extracellular
structures located mainly in the anterior stroma
(Figure 1c and d).
To uncover the cause of these deposits, the proband
underwent genetic testing with the Universal Test
(Avellino Labs China, Shanghai, China) which showed
that he harbored a heterozygous R124H GCD2 mutation
but not the R124C LCD1, R124L RBCD, R555W GCD1 or
R555Q TBCD mutations (Table 1).
Case 2
The proband’s older sister is a 38-year-old female
without any history of ocular surgery, eye complaints, or
decreased vision. Following DNA testing, which revealed
a heterozygous result for the R124H mutation, she was
evaluated by IVCM which demonstrated similar hyper-
reﬂective extracellular opacities at the anterior stroma
with fewer, lower density deposits (Figure 1e and f).
Case 3
GCD2 is an autosomal-dominant disorder caused
by the R124H TGFBI mutation. A study of 10 family
members, in addition to the proband and his sister, was
conducted and a family tree with test results was
constructed (Figure 2d). The proband’s mother and his
15-year-old nephew (his sister’s son) also tested
positive. Slit-lamp examination and IVCM were not
conducted on these individuals due to limited
access to a suitably equipped medical facility. Testing
showed that the proband’s 7-year-old son had not
inherited the mutation. The mutation status of the
proband’s grandparents was unknown. Since the
proband’s aunt tested negative and the medical history
of the deceased uncle is unknown, it is unclear whether
the proband’s mother inherited the mutation or it arose
de novo.
Discussion
Corneal dystrophies contraindicate refractive surgery
due to the likelihood of recurrence and exacerbation. As
they may be difﬁcult to determine by family history and
clinical examination alone, a genetic test to detect TGFBI
mutations should be incorporated into standard practice
as one of the prescreening tools for refractive surgeries.
In Case 1, the patient displayed no clinical symptoms
and passed the LASIK surgery prescreening
examination. Ten years after surgery, he developed
symptoms that affected his vision. A genetic test
identiﬁed that most likely the cause of the stromal
deposits was the TGFBI R124H heterozygous mutation.
The proband’s 15-year-old nephew inherited the
mutation from proband’s sister, who tested positive for
the mutation without symptoms; however, the
examination conducted after the testing revealed that
she too had corneal stromal deposits. These two cases
demonstrate that a lack of clinical signs does not mean
the absence of corneal dystrophy-causing mutations. It
is justiﬁed to test the asymptomatic refractive surgery
candidates to rule out disease-causing mutations.
Corneal dystrophy is a disease with a low prevalence
(US: 1:1115,11 Korea: 1:870,12 China 1:4167) and
debilitating outcome, ultimately resulting in corneal
transplant as a treatment. The recurrent nature of the
disease can result in multiple corneal transplants.
Therefore, prevention and prescreening with a genetic test
to detect the mutations, in addition to a thorough clinical
examination is key.
Table 1 The ﬁve most common TGFBI corneal dystrophies are GDC2, LCD1, RBCD, GCD1, and TBCD
Corneal dystrophy name Exon location Nucleotide change Sequence change Amino-acid change
Granular corneal dystrophy, type 2 4 c.418G4A CGC4CAC p.R124H
Lattice corneal dystrophy, type 1 4 c.417C4T CGC4TGC p.R124C
Reis-Buckler corneal dystrophy 4 c.418G4T CGC4CTC p.R124L
Granular corneal dystrophy, type 1 12 c.1663C4T CGG4TGG p.R555W
Thiel-Behnke corneal dystrophy 12 c.1664G4A CGG4CAG p.R555Q
The respective exon locations, nucleotide changes, and amino-acid changes of their causative mutations are listed (Nucleotide change and Sequence change
information is from HGMD by QIAGEN, Hilden, Germany). A sterile Copan buccal swab (Copan, Brescia, Italy) was used for collecting oral epithelial cells.
The swabs were then sent to Avellino Labs China for testing using the Universal Test, which detects the ﬁve most common TGFBI corneal dystrophies. The
laboratory performed a DNA extraction from the swab using the DNA Extract All Reagents kit (Thermo Fisher Scientiﬁc Inc., Waltham, MA, USA). The
puriﬁed DNA was then ampliﬁed by the TaqMan GTXpress Master Mix (Thermo Fisher Scientiﬁc Inc.) with Life Technology’s 7500 FAST real-time PCR
system (Thermo Fisher Scientiﬁc Inc.). Through a series cycle of denaturing, annealing and extension, the 7500 instrument collects the ampliﬁcation
ﬂuorescence signals of the targets and generates a result from which the genotype may be inferred.
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Figure 1 Slit-Lamp (Nikon Corporation, Tokyo, Japan) photographs of the proband revealed dense, ﬁne, white granules in the central
corneas of both eyes, located at the interface between the ﬂap and stromal bed on the right (a) and left (b) eyes. In vivo confocal microscopy
(IVCM) (Rostock Cornea Module of Retina Tomograph (HRT/RCM); Heidelberg Engineering GmbH, Heidelberg, Germany) images of the
right (c) and left (d) anterior stroma with hyper-reﬂective extracellular deposits. In vivo confocal microscopy (IVCM) images of the right (e)
and left (f) anterior stroma with hyper-reﬂected extracellular deposits observed in the corneas of the proband’s sister.
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What was known before
K Post-LASIK exacerbation of corneal dystrophy is almost
exclusively associated with TGFBI gene mutations.
K Some mutation carriers are asymptomatic.
What this study adds
K Genetic screening of TGFBI mutations must be
incorporated into the pre-operative screening, especially
for those who are asymptomatic.
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